C+D spoke to Mr Green at CPS's first conference on Tuesday (September 6).
He joined delegates including Dr Andrew Buist, deputy chair of the British Medical Association's Scottish GP committee and Scotland's chief pharmaceutical officer Rose Marie Parr to discuss the future of pharmacy in the country.
Watch the video to find out what two key factors Mr Green envisages happening in the coming years.
Find out why pharmacy in Scotland is more forward thinking here.
The views and opinions discussed during this video news blog represent those of the speakers and not of Actavis UK Ltd Actavis
Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard
Adverse events can also be reported to Actavis on 01271 385257
* ‘Patient safety is Actavis’ primary concern and we encourage healthcare professionals and patients to report any adverse event which may occur in relation to an Actavis product. An adverse event includes reports of any side effect, product misuse, abuse or overdose, including inappropriate use by children or women who are pregnant or breast-feeding. It also includes reports of a product that was used for something other than the intended purpose or was ineffective, or was given with another medicine. Complaints relating to the product can also be reported.’